一名70岁的英国人成为欧洲首位接受前列腺癌试验抗体药物的病人. A 70-year-old British man became Europe’s first patient to receive an experimental antibody drug for advanced prostate cancer in a Plymouth trial.

据悉, 70岁的英国人布莱恩·霍尔姆斯 (Brian Holmes) 是欧洲首位接受抗体药物联合剂试验者. A 70-year-old British man, Brian Holmes, has become the first in Europe to receive an experimental antibody drug conjugate in a clinical trial for advanced prostate cancer at Derriford Hospital in Plymouth. 霍姆斯接受了治疗, 这种疗法针对癌细胞而保留健康组织. Diagnosed with metastatic cancer that has not responded to standard treatments, Holmes received the therapy, which targets cancer cells while sparing healthy tissue. 药物在乳腺癌和膀癌中曾经有效, 目前正在严格的检测方案下进行试验, 其名称和制造商未公开. The drug, previously effective in breast and bladder cancers, is being tested under strict protocols, with its name and manufacturer undisclosed. 这项由大学医院普利斯NHS信托所领导的试验标志着针对性治疗癌症患者有限选择的一个重要步骤. The trial, led by University Hospitals Plymouth NHS Trust, marks a significant step in targeted cancer treatment for patients with limited options. 福尔摩斯将这种治疗描述为救生线, 并表示希望它能使其他人受益. Holmes described the treatment as a lifeline and expressed hope it could benefit others.